Viewing StudyNCT00093366



Ignite Creation Date: 2024-05-05 @ 11:36 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00093366
Status: COMPLETED
Last Update Posted: 2011-11-30
First Post: 2004-10-06

Brief Title: Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center

Conditions & Keywords Data

Conditions:
Name
MyelodysplasticMyeloproliferative Diseases
Leukemia
Myelodysplastic Syndromes
Keywords:
Name View
chronic myelomonocytic leukemia View
de novo myelodysplastic syndromes View
previously treated myelodysplastic syndromes View
secondary myelodysplastic syndromes View
myelodysplasticmyeloproliferative disease unclassifiable View
atypical chronic myeloid leukemia View